Mucosa-associated lymphoid tissues contain roughly 80% of all immune cells and produce 16
Mucosa-associated lymphoid tissues contain roughly 80% of all immune cells and produce 16 virtually all of the body's IgA 1-3 . Although the majority of IgA-secreting cells educated 17 within a mucosal site home back to the same anatomic region, some cells are also found in 18 distant mucosal tissues 2-6 . These observations underlie the notion of a common mucosal 19 immune system, which holds that anatomically unrelated mucosal sites are functionally 20 connected by a shared immune system 2,3 . However, the ontological basis of this separation 21 between site of immune education and functionality has remained elusive. Here we show 22 that mice lacking Peyer's patches (PPs)-small-intestinal lymphoid tissue covered by 23 antigen-sampling M cells-have no immunologic defect in the small-intestinal lamina 24 propria. Surprisingly, the primary immunological abnormality in PP-deficient mice was a 25 reduction in colonic B cells, including plasmablasts but not plasma cells. Adoptive transfer 26 experiments conclusively demonstrated that PP-derived cells preferentially give rise to 27 colonic-but not small-intestinal-B cells and plasmablasts. Finally, these PP-derived 28 colonic B cells were critical for restraining colonic inflammation. Thus, PPs bridge the 29 small-intestinal and colonic immune systems and provide a clear example of immune 30 education being required in an anatomic compartment distinct from the effector site. Our 31 findings, which highlight that the majority of fecal IgA is produced by colonic plasmablasts 32 that originate from PPs, will help inform design of mucosal vaccines. 33 34 35 It has long been known that the mucosal immune system is functionally interrelated, 37
with antigens delivered to one mucosal site evoking an immune response in remote 38 mucosal tissues 2,3,7 . Although mucosal lymphocytes have an anatomic affinity for the 39 mucosa of origin, these cells and their antibodies can be found throughout mucosa-40 associated lymphoid tissues and, to a lesser extent, systemic compartments 2-6 . While it is 41 known that there is some compartmentalization within this common mucosal immune 42 system 2,3 , it remains unclear whether this anatomic separation between site of education 43 and functionality is essential to maintaining immune homeostasis. 44
Given that Peyer's patches (PPs)-small-intestinal subepithelial lymphoid 45 aggregates that are covered by a follicle-associated epithelium, including M cells that are 46 specialized for the uptake and delivery of luminal antigens to underlying immune cells-47 are a primary site for immune education within the small intestine 1 , we explored how PPs 48 influence the immune system. Pregnant mice were injected at embryonic day 14 (E14) or 49 E15 with an antibody to interleukin (IL) 7Ra, thereby preventing formation of PPs in their 50 pups 8 . Unlike genetically deficient animals that lack PPs, this approach involves only a 51 transient depletion of lymphocytes during a critical window in embryogenesis and has 52 been demonstrated not to affect formation of small-intestinal isolated lymphoid follicles, 53 the cecal patch, or mesenteric lymph nodes (MLNs) 8, 9 . We found that colonic patches are 54 similarly unaffected (data not shown). 55
Given that M cell formation is dependent on signals from PPs 1,10 , we reasoned that 56 PP-deficient mice also lack M cells. Consistent with this hypothesis, we found that PP-57 deficient mice have fewer viable commensal organisms in the MLNs that drain the small 58 intestine than do control mice (Fig. 1A) ; this observation highlighted the critical role M 59 cells play in transcytosing small-intestinal bacteria 1, 11 . Furthermore, we found that PP-60 deficient mice orally infected with Salmonella enterica serotype Typhimurium-a pathogen 61 known to adhere to and invade via M cells 12 -have a lower small-intestinal burden of 62 mucosa-associated Salmonella than do control mice (Fig. 1B) , a result further suggesting 63 reduced M cell number and/or function. Indeed, flow cytometric analysis of small-intestinal 64 epithelial cells revealed reduced numbers of GP2 + cells, a marker for M cells 13 , in PP-65 deficient mice (Fig. 1C ). Moreover, examination of the distal ileum of PP-deficient mice by 66 transmission electron microscopy demonstrated a complete lack of M cells ( Fig. 1D ). 67
Finally, consistent with the notion that PPs are a critical inductive site for intestinal 68 immunity, PP-deficient mice have drastically reduced levels of fecal IgA (Fig. 1E ). Thus, 69 mice treated with an antibody to IL-7Ra at E14 or E15 have a specific loss of Peyer's 70 patches and M cells, with a resulting defect in IgA production. 71
To more fully understand the impact of PPs on development of the immune system, 72
we performed flow cytometric analyses of various immune compartments. Consistent with 73 previous reports, the loss of PPs has no impact on the number of CD45 + lymphocytes in the 74 spleen, MLNs, or small-intestinal lamina propria (LP) ( Fig. 2A) 8, 14, 15 . Thus, PPs are 75 dispensable for the development of these immune organs. Surprisingly, PP-deficient mice 76 have a lymphopenic colon ( Fig. 2A ). Further characterization of these cells suggested no 77 change in the numbers of colonic TCRb + cells, TCRgδ + cells, or various myeloid cell 78 populations ( Fig. 2B , Extended Data Fig 1) ; rather, there is a significant decrease in the 79 frequency and number of colonic CD19 + cells (Fig. 2C, 2D ). The fact that this decrease in 80 colonic B cells accounted for more than two-thirds of the decrease in colonic CD45 + cells 81 This unexpected finding raised the question of whether PPs are important for the 83 accumulation of B cells in other mucosal sites. To address this question, we examined the 84 lungs of PP-deficient mice and found that they have a normal frequency of B cells ( Fig. 2E ). 85
Given that PPs are known to be a central site for the development of IgA-secreting B cells, 86 we assessed whether IgA + B cells in the colon of PP-deficient mice are similarly affected. 87
Intriguingly, PP-deficient mice have a decreased frequency and number of colonic 88 B220 + IgA + cells (plasmablasts) but no defect in colonic B220 -IgA + cells (plasma cells) (Fig. 89 2F, Extended Data Fig. 2A ). In contrast, there is no difference from control mice in small-90 intestinal plasmablasts or plasma cells (Extended Data Fig. 2B ). In summary, we have 91 established that the absence of small-intestinal PPs affects the ontogeny of B cells, 92 including plasmablasts, specifically in the colon-an anatomically remote site. 93
It is not clear how the loss of PPs leads to a decrease in colonic B cells. One 94 possibility is that prenatal treatment with IL-7Ra antibody affects-in addition to PP 95 development-some other potential source of colonic B cells. It has been demonstrated 96 that peritoneal B1 cells can accumulate in the small-intestinal LP, ultimately developing 97 into plasma cells 16 . It is possible that PP-deficient mice also have a defect in a population of 98 peritoneal B cells that ultimately traffics to the colon. Analyzing the number of CD19 + cells 99 in peritoneal lavage fluid, we found no difference between control and PP-deficient mice 100 ( Fig. 3A) . Moreover, PP-deficient mice have a normal number of colonic B1 cells (CD19 + 101 CD43 + ), B1a cells (CD19 + CD43 + CD5 + ), B1b cells (CD19 + CD43 + CD5 -), and regulatory B 102 cells (CD19 + CD43 + CD5 + CD1d + ) (Extended Data Fig. 3 and data not shown); these results 103 indicate that PP-deficient mice lack colonic B2 cells. In addition, it has recently been the normal number of cecal B cells in PP-deficient mice ( Fig. 3B ) suggests that the decrease 106 in colonic B cells is not due to altered numbers of B cells in the cecum. 107
Given the growing body of evidence on the microbiota's impact on the development 108 of the immune system 7,18 , we wondered whether in utero antibody treatment had affected 109 the microbiota of the dams-and ultimately that of their pups-in a manner that 110 specifically affects colonic B cells. To test this hypothesis, we transferred the fecal 111 microbiota of control or PP-deficient mice into germ-free (GF) mice. Three weeks later, we 112 assessed the frequency and number of colonic B cells in these mice. The lack of difference 113 ( Fig. 3C , Extended Data Fig. 4 ) proves that the colonic B-cell defect in PP-deficient mice is 114 not due to an altered microbiota. 115
Finally, we considered the possibility that prenatal antibody treatment had affected 116 B-cell trafficking-either the ability of B cells to home to the colon or the capacity of the 117 colon to recruit B cells. Analysis of colonic levels of MADCAM1 (a receptor that enables 118 a4b7 integrin-expressing lymphocytes to home to the intestinal LP), CXCL13 (a chemokine 119 that is selectively chemotactic for B cells), and CCL25 and CCL28 (chemokines relevant for 120 homing of B cells to the small and large intestines, respectively) revealed no difference 121 between control and PP-deficient mice (Extended Data Fig. 5 ), demonstrating that these 122 trafficking molecules are not the cause of the colonic B-cell defect in PP-deficient mice. To 123 more robustly examine B-cell trafficking, we performed parabiotic experiments using mice 124 that were congenic for CD45 allotypes (i.e., CD45.1 and CD45.2) and were either PP-125 deficient or PP-sufficient (wild-type, WT) ( Fig. 3D ). As a control, we generated parabiotic 126 pairs of congenic WT mice. As expected, expression of different CD45 allotypes does not 6). While PP-deficient mice have no defect in the recruitment of WT B or T cells in the 129 spleen (Extended Data Fig. 7 ), there is a defect in the recruitment of B cells to the colon 130 ( Fig. 3E) . Given that PP-deficient mice also have a defect in recruitment of B cells to the 131 small intestine and of T cells to the colon and small intestine (without an alteration of cell 132 numbers) (Extended Data Fig. 7) , it is not clear that the recruitment defect of colonic B cells 133 fully explains the decreased number of colonic B cells in PP-deficient mice. 134
An alternative explanation for the paucity of colonic B cells in PP-deficient mice is 135 that a portion of colonic B cells are derived from PPs with no redundant source. If so, we 136 reasoned that the number of colonic B cells should be correlated to that of PPs. Using WT 137 (i.e., PP-sufficient) mice ranging in age from 1 to 18 weeks, we compared the number of B 138 cells in the colon or small intestine with that in PPs. Strikingly, we found a strong 139 correlation in B cell numbers between the colon and PPs (Spearman correlation 0.77; 140 p=0.002) but not between the small intestine and PPs (Spearman correlation 0.00; p=0.99) 141 ( Fig. 3F ). Of note, we remove PPs from the small intestine prior to analysis, but we are 142 technically unable to excise colonic patches before analyzing the colon. If the correlation 143 observed between colonic and PP B cells was due simply to the residual presence of a 144 lymphoid structure in the colon, we predict that numbers of both B and T cells would be 145 correlated given their shared trafficking route through lymphatics. As a control, we 146 analyzed splenic lymphocyte numbers and found a robust correlation of both B and T cells 147 in the spleen and PPs (Fig. 3F, 3G ). However, there is no correlation between T cells in PPs 148 and either the colon or small intestine ( Fig. 3G ). These results indicate that the colon-PP patches and suggest a direct link between these B-cell populations. 151
Next, we exploited the fact that administration of the IL-7Ra antibody at different 152 gestational ages leads to a different number of PPs to test whether the number of PPs 153 present in a mouse is similarly correlated to the number of colonic B cells (Extended Data 154 Fig 8A) 8 . As in the previous experiment relying on mice of various ages, we found-using 155 age-matched mice that differed only in the number of PPs-that the number of colonic B 156 cells is tightly linked to the number of PPs (Extended Data Fig. 8B ; Spearman correlation 157 0.80; p=0.0009). Analysis of mice that were exposed to the IL-7Ra antibody at E18 and had 158 a normal number of PPs revealed a number of colonic B cells similar to that in control mice 159 and greater than that in PP-deficient animals ( Fig. 3H ). Taken together, these data 160 effectively limit any potential off-target effect of the antibody to another structure that, 161 similar to PPs, increases in number between E15 and E18 in an IL-7Ra-dependent, 162 stepwise fashion. Moreover, these correlations significantly strengthen the notion that PP-163
derived B cells form a distinct population of colonic B cells 164
To more conclusively determine whether a subset of colonic B cells is derived from 165 PPs, we performed adoptive transfer experiments, injecting a mixture of PP cells (CD45.1 + ) 166 and a 6-fold excess of splenocytes (CD45.1 + CD45.2 + ) into PP-deficient mice (CD45.2 + ). If 167 PPs truly represent a non-redundant source for a subpopulation of colonic B cells, we 168 conjectured that the donor-derived B cells in the colon would contain a greater percentage 169 of PP cells than the injected mixture. Indeed, while the small intestine contains the same 170 fraction of PP-derived donor B cells as the input, significantly more PP-derived donor B 171 cells are present in the colon of recipient mice (Fig. 3I ). In contrast, the frequency of PP-IgA + B cells in these mice, we found that PP-derived cells preferentially give rise to plasma 174 cells (CD19 -IgA + ) in the small intestine ( Fig. 3J) ; this result was similar to that obtained by 175 Craig and Cebra in seminal work 6 . Extending this work, we found significantly more PP-176 derived plasma cells in the colon as well. Interestingly, the colon-but not the small 177 intestine-also contains significantly increased numbers of PP-derived plasmablasts 178 (CD19 + IgA + ). These data confirm that PP-derived B cells, including plasmablasts, 179 preferentially home to the colon to a greater degree than splenic B cells. Taken together, 180 our data establish the existence of a cohort of colonic B cells that originates from PPs. 181
To determine whether these PP-derived colonic B cells are functionally important, 182
we subjected mice to infection with Citrobacter rodentium, a model of enteropathogenic 183 and enterohemorrhagic Escherichia coli infections in whose control B cells are central 19, 20 . 184 PP-deficient mice have fecal and colonic burdens of C. rodentium greater than those in 185 control mice (Fig. 4A, 4B) . Thus, the loss of PP-derived colonic B cells results in an inability 186 to control infectious colitis. 187
Multiple studies have established that a subset of patients with Crohn's disease-188 particularly those with more severe disease-have elevated titers of autoantibodies to 189 GP2 21-23 , a receptor present on M cells 13 . Therefore, it has been speculated that M cells and 190
PPs may play a role in the pathogenesis of Crohn's disease 24, 25 . To probe this hypothesis 191 and assess whether PP-derived colonic B cells might specifically be involved, we exposed 192 mice to trinitrobenzensulfonic acid (TNBS) in order to induce colitis in a murine model of 193
Crohn's disease 26 . PP-deficient animals lose more weight and have higher disease scores 194 than control mice (Fig. 4C, 4D ). Moreover, animals that are exposed to the IL-7Ra antibody to that in control animals and less severe than that in PP-deficient animals (Fig. 4D) The experiments reported herein demonstrate that PP-derived colonic B cells play a 203 dramatic role in restraining colonic inflammation. We questioned whether these B cells 204 regulate immune responses under healthy, homeostatic conditions. Although PP-deficient 205 mice have dramatically lower levels of fecal IgA than do control mice ( Fig. 1E) , parabiosis 206 to a PP-sufficient mouse, which allows migration of PP-derived B cells into the PP-deficient 207 mouse, can restore fecal IgA levels ( Fig. 4E ). To examine regional differences in the 208 production of IgA, we measured IgA levels in distal ileal contents as a measure of small-209 intestinal IgA. Surprisingly, PP-deficient mice have levels of small-intestinal IgA similar to 210 those in control mice (Extended Data Fig. 10A )-an indication that the lack of PPs and the 211 associated decrease in colonic plasmablasts result in a loss of IgA produced in the colon. 212
Consistent with this finding, colonic segments from PP-deficient mice cultured ex vivo 213 produce lower levels of IgA than those from control mice, whereas there is no difference 214 between cultured ileal segments from the two groups ( Fig. 4F , Extended Data Fig. 10B ). 215
These data support the finding that PPs are critical for IgA production and clarify that the 216 bulk of fecal IgA originates in the colon, a finding consistent with human data 27 . Moreover, 217 although counts of small-intestinal mucosal bacteria do not differ in the two groups of mice 218 burden of mucosal bacteria in PP-deficient mice (Fig. 4G ), which is associated with the 220 development of colitis in mice and humans 28, 29 . Thus, PP-derived colonic B cells are crucial 221 regulators of the colonic immune response in both healthy and inflammatory conditions. 222
Our findings provide a conclusive example of homeostatic antigen sampling in one 223 mucosal compartment being required for the ontogeny and functionality of cells in a 224 distant site. From a teleological perspective, it is not readily apparent why an anatomic 225 defect in the small intestine would lead to an altered immune status specifically in the 226 colon. However, the fundamental physiologic roles of the small and large intestines- Annu. Rev. Cell Dev. Biol. 16, 301-332, doi:10.1146 /annurev.cellbio.16.1.301 (2000 . systemic antibody responses to intestinal antigen. Immunology 44, 543-548 (1981 The middle segments of MLNs, which drain only the jejunum and the ileum 30 , were 373 harvested from control and PP-deficient mice, pressed through a 70-µm cell strainer, and 374 5% sheep blood (BD Biosciences) and Brucella agar with 5% sheep blood, hemin, and 376 vitamin K1 (BD Biosciences). Plates were incubated at 37°C in aerobic and anaerobic 377 conditions (80% N2, 10% H2, 10% CO2), respectively, and colonies were counted after 24 h 378 
Isolation of lymphocytes and flow cytometry 435
Small-intestinal, cecal, and colonic LP lymphocytes were isolated as previously described 31 . 436 In brief, tissues were collected, cleaned of mesenteric fat, and flushed of intestinal contents, 437
and PPs were removed. The tissue segments were inverted, and the epithelial layer was 438 dissociated by incubation in RPMI containing 1.6% FBS, 0.015% DTT, and 1 mM EDTA for 439 15 min at 37°C, with constant stirring at 575 rpm. After washing in RPMI to remove 440 residual mucus, the intestinal segments were finely minced and then incubated in RPMI 441 containing dispase (0.5 mg/ml; Sigma), collagenase II (1.5 mg/ml; Sigma), and 1.2% FBS filtered through a 100-µm and a 40-µm cell strainer prior to flow cytometric analysis. To 444 isolate lymphocytes from spleen, MLNs, and PPs, the organs were pressed through a 70-µm 445 cell strainer. Splenic cells were subsequently incubated in ACK lysis buffer for 2 min on ice 446 and washed in RPMI containing 2% FBS. Lungs were minced and incubated in RPMI 447 containing collagenase (1.5 mg/ml) and DNase I (150 µg/ml; Worthington Biochemical 448 Corp; Lakewood, NJ) for 1 h at 37°C, with constant stirring at 575 rpm. The digested tissue 449 was filtered through a 40-µm cell strainer, incubated in ACK lysis buffer for 2 min on ice, 450 and washed with RPMI containing 2% FBS. For peritoneal lymphocytes, the peritoneal 451 cavity was lavaged with 10 ml of PBS. All samples were resuspended in RPMI containing 452 2% FBS prior to antibody staining for flow cytometric characterization. 453
For flow cytometric detection of M cells, small-intestinal epithelial cells were 454 isolated by the above approach. A primary antibody to GP2 (2F11-C3; MBL Life Science), 455 followed by a PE-conjugated secondary antibody (Biolegend), was used. 456
Fluorophore-conjugated antibodies to the following antigens were used (with 457 clones listed in parentheses): CD45 (30-F11), TCRb (H57-97), TCRgd (UC7-13D5), CD4 458 (GK1.5), CD19 (6D5), CD11b (M1/70), CD11c (N418), B220 (RA3-6B2), IgA (C10-3; BD 459 Biosciences), CD1d (1B1), CD5 (53-7.3), and CD43 (S11). All antibodies were from 460 Biolegend unless indicated otherwise. Cells were permeabilized with the 461 Foxp3/Transcription Factor Staining Buffer Set (eBiosciences) for intracellular staining of 462 IgA. A fixable viability dye conjugated to eFluor 780 (eBioscience) was included in all 463 stains. Flow cytometry was performed with a MACSQuant Analyzer (Miltenyi Biotec), and 464 data were analyzed with FlowJo software (FlowJo; Ashland, OR). 465 as follows: normal appearing=0, soft pellets=1, soft stool with no formed pellets=2, liquid 513 stool=3, appearance of frank blood=4); (4) colon thickness (subjectively scored as 0-4, 514 with 0 being normal); and (5) histology (scored as 0-4, with 0 being normal, by a 515 pathologist blinded to treatment group). As a control, mice that were not sensitized with 516 TNBS and rectally challenged with 50% ethanol (without TNBS) had disease scores of 0-2. 517 518
Quantitative rDNA analysis 519
To quantitatively assess the burden of mucosa-associated bacteria in the intestine, the 520 distal 5 cm of ileum or colon was harvested and flushed with PBS to remove luminal 521 bacteria. The remaining tissue was opened longitudinally and vigorously washed in PBS to 522 liberate the bacteria more closely associated with the epithelium and mucus layer. Genomic 523 DNA was isolated from these mucosa-associated bacterial populations by bead beating 524 followed by phenol-chloroform extraction; fluorescent primer-and probe-based chemistry 525 and a LightCycler 480 II (Roche) were used to quantitate 16S rDNA as previously 526 Schematic of parabiotic mice generated. E. Percentage of colonic CD19 + cells in the indicated host mouse that is derived from the parabiont partner. Lines connect parabiont partners. F, G. Correlation of the numbers of CD19 + (F) and TCRb + (G) cells between PPs and the spleen (red squares), colon (blue circles), or small intestine (SI; yellow triangles). H. Number of colonic CD19 + cells in control mice, PP-deficient mice (exposed to an antibody to IL-7Ra at E15), and mice prenatally exposed to IL-7Ra antibody at E18. I, J. Fraction of PPderived CD19 + (I) and IgA + (CD19 + in dark bars and CD19in gray bars) (J) cells in the input, the SI, or the colon (n=4 recipients for I and J). NS, not significant; *, p<0.05; **, p<0.01. Data are pooled (A, B, E-H) or representative of ≥2 independent experiments (C, I, J). Serial weights (C) and disease score (D) for control mice (blue circles) and mice prenatally exposed to IL-7Ra antibody at E14 (PP-deficient; red squares) or E18 (green triangles) and then subjected to TNBSinduced colitis. E. Levels of fecal IgA in the indicated host mouse 2 weeks after parabiosis with the listed partner. F. Colonic segments were harvested from control and PP-deficient mice and cultured ex vivo. The IgA concentration in the supernatant was measured. G. qPCR-based quantification of mucosa-associated bacteria in the colon. NS, not significant; *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001. Data are pooled (C-D) or representative of ≥2 independent experiments (A-B, E-G).
